Medical/Pharmaceuticals News & Press Release Distribution

Race executes agreement with Ardena for GMP manufacturing of RC220

* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...

2023-07-13 07:30 2907

NeuroXess Documents Its Multiple Achievements in Brain-Computer Interface Research at The 2023 World Artificial Intelligence Conference

SHANGHAI, July 12, 2023 /PRNewswire/ -- On the afternoon of July 6, a forum dedicated to advances in brain-computer intelligence was held at the Shanghai World Expo Exhibition & Convention Center as a part of the 2023 World Artificial Intelligence Conference. The forum was held under the aegis of...

2023-07-12 21:41 2896

NeuroXess Documents Its Multiple Achievements in Brain-Computer Interface Research at The 2023 World Artificial Intelligence Conference

Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences

HONG KONG, Germantown, Md. and SUZHOU, China, July 12, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, hereby...

2023-07-12 20:45 2750

Raya Therapeutic announces early-stage R&D collaboration with argenx

MONTREAL, July 12, 2023 /PRNewswire/ -- Raya Therapeutic Inc., ("Raya") a mission-driven company focused on the treatment of neurodegenerative diseases, has entered into an early-stage R&D collaboration with argenx. The collaboration focuses on testing combinations of Raya's pipeline of targeted ...

2023-07-12 19:07 2239

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

BOSTON, July 12, 2023 /PRNewswire/ -- Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr.Liu Jian as the President of Drug Discovery Division. Medicilon recognizes the importance of drug discovery as the cornerstone of new drug innovation. Wit...

2023-07-12 18:46 2377

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

Best Presentation Award at EASL Congress 2023: First-in-class Bispecific Antibodies Anti-HBs×CD3 and Anti-HBs×CD28 Showed Strong Preclinical Efficacy in HBV Cure

SINGAPORE, July 12, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, together with researchers from the University Medical Center Hamburg-Eppendorf and Technical Unive...

2023-07-12 18:13 2840

Best Presentation Award at EASL Congress 2023: First-in-class Bispecific Antibodies Anti-HBs×CD3 and Anti-HBs×CD28 Showed Strong Preclinical Efficacy in HBV Cure

Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation

SINGAPORE, July 12, 2023 /PRNewswire/ -- On July 6, 2023, Biosyngen received an official notification from the U.S. Food and Drug Administration (FDA) granting Fast Track Designation (FTD) to its revolutionary first-in-class immunotherapy, BRG01, for the treatment of relapsed/metastatic nasophary...

2023-07-12 13:38 3470

Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone.

SINGAPORE, July 12, 2023 /PRNewswire/ -- This is a model of cooperation between Singapore and China, more importantly, working jointly in the area of research and development. Through this initiative, China Singapore Knowledge City paths the way to attract both local and overseas therapeutic asse...

2023-07-12 10:32 3244

Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone.

Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism

HANGZHOU, China and SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the publication of discovery, preclinical characteriza...

2023-07-12 10:00 2532

GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®

BOSTON, July 11, 2023 /PRNewswire/ -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®. This transformative shift r...

2023-07-12 07:12 2232

Bridge Biotherapeutics Joins PROLIFIC, the Prognostic Lung Fibrosis Consortium

Bridge to join as an industry member to advance the science of early detection and speed development of novel treatments SEONGNAM, South Korea and CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel dru...

2023-07-12 06:00 2049

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

TAIPEI, July 12, 2023 /PRNewswire/ -- As cell therapies continue to rank among the most expensive of cancer treatments,BeiGene is quietly charting a different path that would enable more equitable access for all.

2023-07-12 06:00 2421

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF FULL-SPECTRUM CLINICAL FLOW CYTOMETRY

Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, announces the laun...

2023-07-11 20:05 2938

AXA Upgrades "Dr@Live" with New Features

One-stop service encompassing eQueuing, eAppointment, doctor consultation and same-day medicine delivery HONG KONG, July 11, 2023 /PRNewswire/ -- AXA Hong Kong & Macau ("AXA") announced today the launch of the enhanced "Dr@Live" medical service, providing a seamless one-stop health management ex...

2023-07-11 16:32 2300

Doer Biologics Announces License Agreement with BioNTech

HANGZHOU, China, July 10, 2023 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announced that it has entered into a license agreement with BioNTech SE (Nasdaq...

2023-07-11 11:49 1952

Race executes global license agreement with City of Hope to access FTO IP

* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...

2023-07-11 07:30 2437

SOUND OF FREEDOM, EXECUTIVE PRODUCED BY GOYA CARES, SOARS IN THEATERS

Film Brings Evil into Light and Hope to Two Million Trafficked Children JERSEY CITY, N.J., July 11, 2023 /PRNewswire/ -- Goya Cares, an executive producer of the new blockbuster movie SOUND OF FREEDOM, celebrates the overwhelming success of surpassing the goal of over two million viewers to repr...

2023-07-11 07:25 2948

SOUND OF FREEDOM, EXECUTIVE PRODUCED BY GOYA CARES, SOARS IN THEATERS

Shanghai Electric Shares A Long-term Cooperation Opportunity with Siemens, Strengthening Innovation in New Energy and Healthcare

SHANGHAI, July 11, 2023 /PRNewswire/ -- Shanghai Electric (SEHK:2727, SSE:601727) ("the Company") discussed the long-term cooperation opportunity with Siemens to boost technological innovation in the healthcare and energy sectors in a recent visit paid by the top executives from Siemens Healthine...

2023-07-11 07:09 2880

Quest PharmaTech Provides Product Development Update

EDMONTON, AB, July 11, 2023 /PRNewswire/ -- Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies announced that a U.S patent has been granted...

2023-07-11 04:30 2119

Race executes global license agreement with City of Hope to access FTO IP

* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...

2023-07-10 19:30 1864